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Homeodomain-Interacting Protein Kinase-2
Regulates Apoptosis in Developing Sensory
and Sympathetic Neurons
on the on the pro-apoptotic effects of HIPK2 in various
cell lines [7, 8] raised the possibility that it may play a
role in regulating neuronal apoptosis during develop-
ment. To determine if HIPK2 is expressed in experimen-
tally tractable populations of neurons, we used competi-
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P.O. Box 911 tive RT/PCR to measure the levels of HIPK2 mRNA in
three well-characterized groups of peripheral sensoryCardiff CF10 3US
Wales and sympathetic neurons. Trigeminal, nodose, and su-
perior cervical ganglia were dissected from CD1 mouseUnited Kingdom
2 Department of Pathology embryos at stages during the phase of naturally oc-
curring neuronal death. Figure 1 shows that HIPK2 wasUniversity of California, San Francisco
and Veterans Affairs Medical Center detectable in all three ganglia. Whereas the levels HIPK2
mRNA relative to mRNA for the housekeeping proteinSan Francisco, California 94121
GAPDH were essentially unchanged throughout this pe-
riod of development in the nodose and superior cervical
ganglia (SCG), there was a marked developmentalSummary
change in the expression of HIPK2 relative to GAPDH
mRNA in the trigeminal ganglion. From a peak at E12,Excess neurons in the developing nervous system are
the relative level of HIPK2 mRNA falls 3-fold by P1.eliminated by apoptosis, an ordered cascade of pro-
The peak expression just precedes the peak numberteolytic events orchestrated by the caspase family of
of neurons in the trigeminal ganglion at E13, and theproteases [1]. The apoptotic machinery is tightly regu-
decrease in expression occurs throughout the period oflated by a variety of extracellular signals that either
naturally occurring neuronal death, which is completeactivate or suppress apoptosis after binding to recep-
by birth. Over this period of development, about half thetors on neurons [2]. These signals are integrated in
number of neurons in the ganglion die by apoptosis [10,neurons by a complex network of protein-protein in-
11]. Thus, the levels of HIPK2 in the trigeminal ganglionteractions that bring about transcriptional and post-
are high during at the commencement of naturally oc-translational changes in key regulators of the apo-
curring death and much lower at the end of this phaseptotic machinery; such regulators include members of
of development.the Bcl-2 family [3]. Homeodomain-interacting protein
To determine whether HIPK2 is expressed in neurons,kinase-2 (HIPK2) is a recently identified nuclear serine-
we used differential sedimentation to separate neuronsthreonine kinase that interacts with homeodomain
from neuronal cells in the trigeminal ganglion at E18 andtranscription factors [4, 5] and participates in the regu-
P1, when the size difference between neurons and otherlation of cell growth [6] and genotoxic stress-induced
cell types is sufficient to allow neuron preparations toapoptosis [7, 8]. Here we show that overexpression of
obtain greater than 95% purity. Figure 1 shows a clearHIPK2 in developing neurotrophin-dependent sensory
HIPK2 mRNA signal in these purified neurons, indicatingand sympathetic neurons promotes apoptosis of these
the HIPK2 is present in developing neurons.neurons grown with neurotrophins. HIPK2-induced
apoptosis is caspase-dependent, is inhibited by over-
expression of Bcl-2 and Bcl-W, and fails to occur in
Overexpression of HIPK2 Induces ApoptosisBax-deficient neurons. Trigeminal sensory neurons,
in Sensory and Sympathetic Neuronswhich are especially susceptible to HIPK2-induced
We began investigating the potential effect of HIPK2apoptosis, express the highest levels of HIPK2 during
on neuronal survival by overexpressing this protein inthe peak of apoptosis in vivo. Knockdown of endoge-
neonatal neurons cultured in the presence of a neuro-nous HIPK2 with antisense oligonucleotides substan-
trophin that promotes their survival (nerve growth factortially reduces and delays apoptosis after neurotrophin
[NGF] in the case of trigeminal and SCG neurons anddeprivation in vitro. These findings identify HIPK2 as
brain-derived neurotrophic factor [BDNF] in the case ofa novel participant in programmed cell death in the
nodose neurons). Dissociated, purified neurons weredeveloping peripheral nervous system.
plated and grown overnight with the respective neuro-
trophin and microinjected with either a plasmid express-
Results and Discussion ing HIPK2 or an empty control plasmid. Injected neurons
were cultured for an additional 96 hr in the presence of
HIPK2 Expression in Developing Sensory neurotrophin, and the number of surviving neurons was
and Sympathetic Ganglia counted 48 and 96 hr after injection. Figure 2 plots the
The predominant expression of Homeodomain-inter- number of surviving neurons at these time points and
acting protein kinase-2 (HIPK2) in the brain, spinal cord, expresses them as a percentage of the number injected.
and retina of fetal mice [9] together with previous work Whereas virtually all control-injected neurons were still
surviving after 96 hr, overexpression of HIPK2 caused
highly significant decreases in survival in all three kinds*Correspondence: doxakise@cf.ac.uk
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indicate that HIPK2 is capable of bringing about the
death of developing, neurotrophin-dependent sensory
and sympathetic neurons.
HIPK2 Kills Neurons by a Caspase-Dependent,
Bax-Dependent Mechanism
We began investigating the mechanism by which HIPK2
overexpression promotes neuronal death by determin-
ing whether it depends on caspases, the proteases that
dismantle the cell in programmed cell death. Because
of the pronounced effect of HIPK2 overexpression on
trigeminal neurons, we focused on these neurons. Figure
3 shows that the pancaspase inhibitor Z-VAD-FMK
largely prevented HIPK2-induced death of trigeminal
neurons: there was no significant difference in the num-
ber of Z-VAD-FMK-treated HIPK2-overexpressing neu-
rons and control-injected neurons by 48 hr, and by 96
hr only 27% of the HIPK2-overexpressing neurons had
died in Z-VAD-FMK-treated, cultures compared with un-
treated neurons. These results indicate that HIPK2-
induced neuronal death is a caspase-dependent pro-
cess.
Because members of the Bcl-2 family are key regula-
tors of caspase activation [3], we investigated whether
manipulating the expression of pro-apoptotic and anti-
apoptotic members of this family could rescue trigemi-
nal neurons from HIPK2-induced cell death. Among the
proapoptotic Bcl-2 proteins, Bax plays a key role inFigure 1. Developmental Changes in the Level of HIPK2 mRNA in
Sensory and Sympathetic Ganglia regulating the survival of sensory and sympathetic neu-
rons. Targeted deletion of Bax largely prevents naturallyThe level of HIPK2 mRNA relative to GAPDH mRNA was measured
at two-day intervals in the trigeminal ganglion from E10 to P1, in occurring neuronal death of these neurons in vivo and
the nodose ganglion from E12 to P1, and in the SCG from E14 to substantially reduces apoptosis after neurotrophin with-
P1. The relative levels of HIPK2 mRNA are also shown for purified drawal in vitro [12, 13]. We therefore established cultures
trigeminal ganglion neurons at E18 and P1. The means and standard
from Bax-deficient neonates to see if Bax is requirederrors of four independent measurements at each age are shown.
for HIPK2-induced cell death. Figure 3 shows that Bax-
deleted neurons were almost completely protected from
HIPK2-induced neuronal death, indicating HIPK2-inducedof neurons at both time points. Similar decreases were
observed in BDNF-supplemented nodose neurons and apoptosis requires Bax.
Anti-apoptotic members of the Bcl-2 family preventNGF-supplemented SCG neurons (approximately 18%
reduction relative to control-injected neurons at 48 hr apoptosis in part by dimerizing with and inhibiting the
function of pro-apoptotic members of this family. Over-and between 55% and 64% reduction at 96 hr). However,
HIPK2 overexpression was most effective in promoting expression of the anti-apoptotic proteins such as Bcl-2
and Bcl-W in developing sensory and sympathetic neu-the death of trigeminal neurons; 73% were already dead
by 48 hr, and 94% were dead by 96 hr. These results rons can rescue a substantial number after neurotrophin
Figure 2. HIPK2 Overexpression Kills Sen-
sory and Sympathetic Neurons Grown with
Neurotrophins
Cultures of newborn mouse trigeminal, no-
dose, and SCG neurons were grown over-
night with either 20 ng/ml NGF (trigeminal and
SCG neurons) or 20 ng/ml BDNF (nodose
neurons), then injected with either the HIPK2
expression plasmid or an empty control plas-
mid (pcDNA3.1 without an insert) and incu-
bated for an additional 96 hr with 5 ng/ml
of the same neurotrophin. The numbers of
surviving neurons were counted at 48 and 96
hr after injection and expressed as a percent-
age of the number injected. The means and
standard errors of the results of four separate
experiments are shown. In each experiment,
80–150 neurons were injected for each exper-
imental condition.
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out NGF. After NGF deprivation, control-injected sympa-
thetic neurons died very rapidly (Figure 4A), and control-
injected trigeminal neurons died more slowly (Figure
4B). These losses were very similar to those observed
in uninjected, NGF-deprived sympathetic and sensory
neurons, respectively (data not shown). In marked con-
trast, antisense-injected neurons died much more slowly.
Whereas virtually all control-injected sympathetic neu-
rons were dead 48 hr after NGF deprivation, 35% of
antisense-injected neurons were still surviving at this
time (Figure 4A). Whereas 59% of control-injected tri-
geminal neurons were dead 48 hr after NGF deprivation,
only 18% of antisense-injected neurons had died at this
time, and by 96 hr, the loss of antisense-injected neurons
was only 41%, compared with 75% of control neurons
(Figure 4B). To confirm that the antisense HIPK2 oligo-
nucleotides reduce HIPK2 expression, we transfected
CHO-K1 cells with these oligonucleotides and assessed
the level of HIPK2 mRNA 15 hr later by RT-PCR. Figure
4C shows a clear reduction in the HIPK2 signal in anti-
sense-transfected cells compared with control trans-
fected cells. Taken together, these results suggest that
HIPK2 plays an important role in bringing about the
Figure 3. Inhibition of HIPK2-Induced Apoptosis by Caspase Inhibi- death of NGF-dependent neurons deprived of NGF. In-
tion and Bcl-2 Proteins terestingly, the cell bodies of the antisense HIPK2-trans-
Cultures of newborn mouse trigeminal neurons were grown over- fected neurons surviving without NGF were much
night with 20 ng/ml NGF, then injected with plasmids expressing smaller than those of neurons grown with NGF (not
HIPK2, Bcl-2, or Bcl-W alone or in combination, as indicated. For shown). This appearance is reminiscent of the atrophic
the caspase inhibition experiments, the Z-VAD-FMK pancaspase
cell bodies of Bax-deficient neurons surviving in cultureinhibitor was added to cultures at a concentration of 75 M immedi-
without NGF [12].ately after injection. The number of surviving neurons was counted
after an additional 48 and 96 hr incubation in medium containing 5 Because of the very rapid death of P1 sympathetic
ng/ml NGF and expressed as a percentage of the number injected. neurons after NGF deprivation and the especially clear
To study the effect of the absence of Bax on HIPK2-induced apopto- effect of HIPK2 knockdown in rescuing these neurons,
sis, cultures were established from Bax/ mice (Bax/  HIPK2) we investigated whether NGF deprivation might affect
and wild-type littermates (control and HIPK2). The means and stan-
expression of HIPK2 mRNA in these neurons. For thesedard errors of the results of four separate experiments are shown.
experiments the neurons were grown with and withoutIn each experiment, 80–150 neurons were injected for each experi-
mental condition. NGF for 48 hr, and RT/PCR was used to assess the
relative levels of HIPK2 mRNA. To maintain similar num-
bers of neurons under both experimental conditions,
withdrawal [14–16]. For this reason, we also investigated the cultures were supplemented with the pancaspase
whether overexpressing Bcl-2 and Bcl-W could prevent inhibitor Z-VAD-FMK to prevent cell death. After 48 hr
HIPK2-induced neuronal death. As shown in Figure 3, incubation, the level of HIPK2 mRNA was significantly
overexpression of either Bcl-2 or Bcl-W largely inhibited elevated 2.17-  0.07-fold in NGF-deprived neurons
the HIPK2-induced apoptosis, Bcl-2 being somewhat compared with NGF-treated neurons (p  0.003, t test,
more effective than Bcl-W. Overexpression of the anti- n  4 independent experiments). This suggests that
apoptotic Bcl-XL protein also markedly inhibited the death HIPK2 function is regulated at least in part at a transcrip-
of HIPK2-transfected trigeminal neurons, although not as tional level in these neurons after NGF deprivation.
effectively as Bcl-2 and Bcl-W (data not shown).
Endogenous HIPK2 Facilitates Apoptosis Conclusions
We have identified HIPK2 as an important participantof NGF-Deprived Neurons
The demonstration that overexpression of HIPK2 causes in programmed cell death in the developing peripheral
nervous system. HIPK2 is expressed in sensory andBax-dependent apoptosis in neurons grown with NGF
raised the possibility that HIPK2 normally plays a role sympathetic neurons during the stage of programmed
cell death in vivo. Overexpression of HIPK2 kills thesein programmed cell death in the developing nervous
system. To investigate this possibility directly, we in- neurons by a caspase-dependent mechanism in the
presence of neurotrophins, and knockdown of endoge-jected antisense HIPK2 oligonucleotides into cultured
neurons to reduce expression of endogenous HIPK2 nous HIPK2 inhibits apoptosis after neurotrophin with-
drawal in vitro. These findings suggest that HIPK2 playsprotein and see if this would prevent neuronal death after
NGF deprivation. In these experiments, sympathetic and a role in bringing about apoptosis in neurons that fail
to obtain an adequate supply of neurotrophic factorstrigeminal neurons were grown with NGF overnight and
injected the following morning with antisense HIPK2 or in vivo. HIPK2 has previously been implicated in regulat-
ing apoptosis in various cell lines by several differenta control oligonucleotide and subsequently grown with-
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Figure 4. Endogenous HIPK2 Facilitates Apo-
ptosis of NGF-Deprived Neurons
Cultures of newborn mouse SCG neurons (A)
and trigeminal neurons (B) were grown over-
night with 20 ng/ml NGF, then injected with
either antisense HIPK2 or control oligonucle-
otides. They were then grown in medium with-
out NGF. The number of surviving neurons was
counted at 24-hourly intervals and expressed
as a percentage of the number of injected neu-
rons. The means and standard errors of the
results of four separate experiments are shown.
In each experiment, 80–150 neurons were in-
jected for each experimental condition. (C)
Gels showing HIPK2 and GAPDH PCR prod-
ucts derived from reverse-transcribed RNA
obtained from CHO-K1 cells 15 hr after trans-
fection with either antisense HIPK2 or control
oligonucleotides. The levels of GAPDH are
very similar in antisense HIPK2 and control
transfected cells, whereas the level of HIPK2
is very clearly reduced in the antisense-trans-
fected cells.
neurons could be distinguished from non-microinjected neurons.mechanisms. In response to genotoxic stress, HIPK2
After injection, the neurons were grown in medium containing 5 ng/promotes p53-mediated apoptosis by phosphorylating
ml of the same neurotrophins unless otherwise stated. The numberp53 [7, 8] and by inhibiting the p53 negative regulator
of surviving neurons was counted at 24- or 48-hourly intervals after
MDM2 [17]. HIPK2 phosphorylates the transcriptional injection and is expressed as a percentage of the number of injected
corepressor CtBP, resulting in proteosomal degradation neurons. Around 100 neurons were injected for each experimental
condition in each experiment.of CtBP and induction of proapoptotic genes indepen-
dently of p53 [18]. HIPK2 also positively regulates TGF-
-induced JNK activation and apoptosis independently Measurement of HIPK2 mRNA
A semiquantitative RT/PCR assay determined the expression pat-of p53 [19]. Although the mechanisms by which HIPK2
tern of HIPK2 mRNA in dissected ganglia, purified neurons, andbrings about apoptosis in developing neurons remain
cultured neurons. Total RNA was purified with the nucleospin RNAto be ascertained, it should be noted that p53 and JNK
II kit (Macherey-Nagel) and recovered in 100–1,000 l (depending
have been implicated in sympathetic neuron apoptosis on the tissue size) of DEPC-treated H2O. The RNA was reverse
after NGF deprivation [20, 21]. In addition to defining transcribed for 1 hr at 37C with superscript enzyme (Invitrogen) in
the transcriptional and posttranslational events that me- a 30 l reaction containing the manufacturers’ buffer supplemented
with 0.5 mM dNTPs (MBI Fermentas) and 10 M random hexa-diate the proapoptotic effects of HIPK2 in developing
nucleotides (Amersham). A 3 l aliquot of each reverse transcriptionneurons, it will be important in future work to ascertain
reaction was amplified in a 30 l PCR reaction containing 1 	 PC2whether extracellular signals that regulate neuronal sur-
buffer (Helena BioSciences), 0.1 mM dNTPs, 0.85 units of Taq Su-
vival and death influence the expression and/or kinase preme (Helena BioSciences), and 20 pmol primers. The forward and
activity of HIPK2. In summary, our work has revealed reverse primers for HIPK2 were 5
-GCCTACCTTACGAGCAGACC-




primers hybridize 121 bp apart in the mouse HIPK2 sequence. HIPK2developing neurons.
cDNA was amplified by cycles at 95C for 50 s, followed by 50 s at
53C, followed by 50 s at 68C. The reaction was completed with aExperimental Procedures
10 min extension at 68C. The reproducibility of the HIPK2 results
were ascertained by repetition of each PCR twice for two differentNeuron Cultures and Microinjection
(27 and 29) numbers of cycles. The cycling conditions were optimalDissociated cultures of neurons from the trigeminal, nodose, and
for the amplification of the HIPK2 transcript so that the rate ofSCG of newborn or postnatal-day (P1) mice were set up as described
reaction did not plateau. Quantitative, competitive RT/PCR was alsopreviously [22] except that the neurons were purified free of nonneu-
used for determining the amount of mRNA for the housekeepingronal cells via a percoll gradient (Amersham) and were grown in
GAPDH protein in each RNA sample [15]. The PCR products wereneurobasal medium with B-27 supplement and glutamax (In-
separated on 8% nondenaturing polyacrylamide gels. These gelsvitrogen). After cultures were incubated overnight with either 20
were subsequently stained with SyberGold (Cambridge Biosci-ng/ml NGF (trigeminal and SCG) or 20 ng/ml BDNF (nodose), intra-
ences), and the intensity of the RT-PCR products was determinednuclear injection of expression plasmids or antisense oligonucleo-
via a gel documentation system (Biogene) with Phoretix softwaretides was carried out [15]. Plasmid DNA, prepared with the QIAfilter
(Phoretix International).midiprep kit (Qiagen), and oligonucleotides (Proligo) were injected
in phospho-buffered saline (PBS) (pH 7.4) at final concentrations of
0.15 g/ml and 2 g/ml, respectively. The HIPK2 antisense oligonu- Validation of HIPK2 Knockdown by Antisense
Oligonucleotidescleotide was an LNA-DNA-LNA gapmer with the following sequence:
5
-gggCCACCGCGGCCATggat-3
. The control was an LNA-DNA- CHO-K1 cells were transfected with the antisense and control LNA-
DNA-LNA gapmers with Optimem and Oligofectamine in accor-LNA gapmer with no homology to any known sequence: 5
-cctaGC
GTGACGCtatc-3
. A fluorescent dextran dye, Alexa Fluor (Molecular dance with the manufacturer’s instructions (Invitrogen). After 15 hr,
RNA purification and RT-PCR were carried out as described above.Probes, Eugene, OR), was coinjected (final concentration 0.35
mg/ml) with the plasmid or oligonucleotide so that microinjected The forward primers for HIPK2 and GAPDH were 5
-TGGTCAAGTG
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